Verzenio to be studied in a Phase II trial in AR+ breast cancer patients

Press/Media

Period	18 Dec 2018

Media coverage

Title	Verzenio to be studied in a Phase II trial in AR+ breast cancer patients
Media name/outlet	Pharmaceutical Technology
Country/Territory	United States
Date	18/12/18
URL	https://www.pharmaceutical-technology.com/comment/androgen-receptor-breast-cancer-treatment/
Persons	Amy Tiersten